Ipsen (United States)
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Ipsen (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
55%
Total
Publications
355
Total Open
Publications
194
Total
Citations
5.1K
Open Access
Percentage
55%
Total
Publications
355
Total Open
Publications
194
Total
Citations
5.1K
Breakdown
Publisher Open
26%
Both
27%
Other Platform Open
2%
Closed
45%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 23%
43
Hybrid 65%
121
No Guarantees 12%
22
Other Platform Open
Domain 87%
90
Institution 18%
19
Public 12%
12
Other Internet 11%
11
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 90 |
Europe PMC | Domain | 30 |
Semantic Scholar | Public | 9 |
Le Centre pour la Communication Scientifique Directe - HAL - TYPE ART | Other Internet | 5 |
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia | Other Internet | 3 |
University of Edinburgh - Edinburgh Research Explorer | Institution | 2 |
University College London - UCL Discovery | Institution | 2 |
Umeå University - DiVA at Umeå University | Institution | 2 |
INFN Catania - INFM-OAR | Other Internet | 2 |
Ghent University - Ghent University Academic Bibliography | Institution | 2 |